Form 4: Insight Holdings Group Sells Hinge Health Stock

Insight Holdings Group, LLC reported transactions involving Hinge Health, Inc. (HNGE) Class A Common Stock on June 24, 2026.

Summary

• Insight Holdings Group, LLC and affiliated entities reported transactions related to Hinge Health, Inc. (HNGE) on June 24, 2026.
• These transactions involved the disposition of Class A Common Stock.
• The reporting persons are Insight Holdings Group, LLC, Insight Venture Associates X, Ltd., Insight Venture Associates X, L.P., Insight Venture Partners X, L.P., Insight Venture Partners (Cayman) X, L.P., Insight Venture Partners (Delaware) X, L.P., and Insight Venture Partners X (Co-Investors), L.P.
• The transactions were made pursuant to a Rule 10b5-1 plan adopted on August 20, 2025.
• Class B Common Stock was converted into Class A Common Stock on June 22, 23, and 24, 2026, prior to or in conjunction with the reported dispositions.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a slightly negative sentiment due to the significant disposition of shares by a major holder, even though it was executed under a pre-planned trading strategy.

Negatives

• Insight Holdings Group, LLC and its affiliated entities disposed of a significant number of Hinge Health, Inc. Class A Common Stock shares.
• Specifically, 119,244 shares were disposed of at a weighted average price of $71.6669, and an additional 23,067 shares were disposed of at the same weighted average price.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for significant shareholders and insiders, indicating changes in beneficial ownership. The specific details of the transactions, including the use of a Rule 10b5-1 plan, suggest a pre-arranged selling strategy.

Stakeholder Impact

• Shareholders may view the sale of a large block of shares by a significant holder as a potential indicator of future price pressure or a lack of confidence, despite the Rule 10b5-1 plan.
• The transactions do not appear to directly impact employees, customers, suppliers, or creditors based on the information provided.

Key Dates

Recommendation

The filing indicates a significant sale of stock by a major holder, Insight Holdings Group, executed under a Rule 10b5-1 plan. While this represents a reduction in their stake, the use of a pre-arranged plan mitigates concerns about insider selling based on non-public information. The sale itself could create downward price pressure, but without further context on the holder's overall remaining stake or Hinge Health's performance, a 'hold' recommendation is prudent, suggesting investors monitor further developments.

Keywords

Form 4, SEC Filing, Insider Trading, Stock Sale, Hinge Health, HNGE, Insight Holdings Group, Beneficial Ownership, Class A Common Stock, Rule 10b5-1